Approval · Notice of Compliance 1577 · 2003
3TC: Notice of Compliance 1577
Issued August 26, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1577
- Date
- August 26, 2003
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength and new 300 mg once daily dosing regimen
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| 3TC | 02247825 | Marketed |
| 3TC | Not yet assigned | — |
Medicinal ingredients
- LAMIVUDINE 300 MG per TAB
- LAMIVUDINE 150 MG per TAB
- LAMIVUDINE 10 MG per ML